Tony Donghong Li from Irvine, CA

Resumes

Tony Li Westminster, CA

View page

Work:

Prosperitech

Jan 2011 to Present
Marketing Coordinator
SK&A Research
Irvine, CA
Aug 2011 to Dec 2011
Data Entry Technician
Web Medics
Santa Ana, CA
Jan 2011 to Jan 2011
Freelance SEO copywriter and consultant
Huntington Beach Central Library

Jan 2009 to Jan 2010
Volunteer
Interval House
Long Beach, CA
Jan 2008 to Jan 2010
Volunteer
Fry's Electronics
Fountain Valley, CA
Jul 2008 to Dec 2009
Sales Associate

Education:

California State University Fullerton
2011
Bachelor of Art in Business Administration, Entrepreneurship

Skills:

Project Management, Lead Generation, Social Media Management, Market Research and Analysis, Project planning/development/launch, Business Development, Google Analytics, Online Marketing

Business Records

Name / Title

Company / Classification

Phones & Addresses

Tony Li
President

GMAC Finance Group Inc

17588 Rowland St, Whittier, CA 91748
832 Padilla St, San Gabriel, CA 91776

Tony Li
President

W C C Honey Marketing, Corp
Honey Processing

636 Turnbull Cyn Rd, Whittier, CA 91745
PO Box 92611, Whittier, CA 91715
(626) 855-3086

Tony Li
Manager

Epic Aquatics Inc
Business Services at Non-Commercial Site

1457 Nogales St, Whittier, CA 91748

Tony Li

Thomas & Tony, LLC

11 Eccelstone Cir, Irvine, CA 92604

Tony Li

Ample USA Investment, LLC

2001 Palma Dr, Whittier, CA 91748

Tony Li
Owner

ROCKY TRADING CORPORATION
Whol Nondurable Goods

9504 Lemon Ave, Temple City, CA 91780

Tony Li
President

PACIFIC AQUARIUMS WORLD INC
Botanical/Zoological Garden

775 Columbia St, Brea, CA 92821
1405 Pioneer St, Brea, CA 92821

Tony W. Li
President

SUPERPOWER, INC

3129 S Hacienda Blvd SUITE 383, Hacienda Heights, CA 91745
3129 S Hacienda Blvd, Whittier, CA 91745

Publications

Us Patents

Method Of Detection And Treatment Of Colon Cancer By Analysis Of Beta-Catenin-Sensitive Isoforms Of Lymphoid Enhancer Factor-1

View page

US Patent:

20020169300, Nov 14, 2002

Filed:

Jan 29, 2002

Appl. No.:

10/060844

Inventors:

Marian Waterman - Irvine CA, US
Randall Holcombe - Cotode Caza CA, US
J. Marsh - Newport Beach CA, US
Karine Hovanes - Westminster CA, US
Tony Hung Li - Los Angeles CA, US

International Classification:

C07H021/02
C07H021/04
C07K001/00
C07K014/00
C07K017/00

US Classification:

536/023100, 530/350000

Abstract:

The present invention relates to the discovery that LEF1 is a new type of target gene in that it is ectopically activated in colon cancer. The pattern of this ectopic expression is unusual because it derives from selective activation of a promoter for a full-length LEF1 isoform that binds -catenin, but not a second, intronic promoter that drives expression of a dominant negative isoform. -catenin/TCF complexes can activate the promoter for full-length LEF1 suggesting that in cancer, high levels of these complexes misregulate transcription to favor a positive feedback loop for Wnt signaling by inducing selective expression of full length, -catenin sensitive forms of LEF/TCFs. The invention provides diagnostic and therapeutic methodologies based on the discoveries described herein.

Method Of Detection And Treatment Of Colon Cancer

View page

US Patent:

20020187502, Dec 12, 2002

Filed:

Apr 25, 2002

Appl. No.:

10/134092

Inventors:

Marian Waterman - Irvine CA, US
Randall Holcombe - Coto de Caza CA, US
J. Marsh - Newport Beach CA, US
Karine Hovanes - Westminster CA, US
Tony Hung Li - Los Angeles CA, US

International Classification:

C12Q001/68
G01N033/574

US Classification:

435/006000, 435/007230

Abstract:

The present invention is based, in part, on the discovery that colon carcinoma, carcinogenesis, or the predisposition thereto is associated with the level of Wnt2, Wnt5, BMP6, and Fz receptors and the full-length and dominant negative form of LEF1.

Videos & Images